Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
Rev Assoc Med Bras (1992) ; 69(3): 415-420, 2023.
Article in English | MEDLINE | ID: mdl-36921196

ABSTRACT

OBJECTIVE: The aim of this study was to determine frequency and associations between APOA5 c.56C>G, -1131T>C, c.553G>T, and APOC3 -482C>T and SstI gene polymorphisms with hypertriglyceridemia. METHODS: Under a case-control study model, 135 hypertriglyceridemic and 178 normotriglyceridemic control participants were recruited. Polymerase chain reaction and restriction fragment length polymorphism methods were utilized for genotyping. Statistical calculations were performed by comparing allele and genotype frequencies between groups. Clinical characteristics were compared between groups and intra-group genotypes. RESULTS: APOC3 gene -482C>T and SstI polymorphic genotypes and allele frequencies were significantly higher in hypertriglyceridemic group (genotype frequencies, p=0.035, p=0.028, respectively). Regression analysis under unadjusted model confirmed that APOC3 -482C>T and SstI polymorphisms were significantly contributing to have hypertriglyceridemia (p=0.02, odds ratio [OR]=1.831 (95% confidence interval [CI] 1.095-3.060); p=0.04, OR=1.812 (1.031-3.183), respectively). APOA5 c.56C>G was in complete linkage disequilibrium with APOA5 c.553G>T polymorphism (D'=1). CONCLUSION: For the first time in a population sample from Turkey, among the five polymorphisms of APOA5 and APOC3 genes investigated, APOC3 -482C>T and SstI polymorphisms were associated with elevated serum TG levels, while APOA5 c.56C>G, -1131T>C, and c.553G>T polymorphisms were not.


Subject(s)
Apolipoprotein A-V , Apolipoprotein C-III , Hypertriglyceridemia , Humans , Apolipoprotein A-V/genetics , Apolipoprotein C-III/genetics , Case-Control Studies , Gene Frequency , Genotype , Haplotypes , Hypertriglyceridemia/genetics , Polymorphism, Single Nucleotide , Triglycerides
2.
Clin Investig Arterioscler ; 35(2): 53-63, 2023.
Article in English, Spanish | MEDLINE | ID: mdl-35961839

ABSTRACT

BACKGROUND AND AIMS: Triglycerides are the initiators of the metabolic changes that lead to atherogenic dyslipidemia (AD). The APOA5 and APOA1 genes are involved in the response and metabolism of serum lipids and lipoproteins, where single nucleotide polymorphisms (SNP) rs662799 (promoter region) and rs5070 (intronic region) have been associated with the susceptibility to dyslipidemia. Until now, few studies evaluate the association of these polymorphisms with the presentation of hypertriglyceridemia and AD among Mexican children. Therefore, the objective was to determine the association between rs662799 and rs5070 with hypertriglyceridemia and AD in a pediatric population of southeastern Mexico. MATERIALS AND METHODS: A case-control analysis was performed including 268 infants aged 2-16 years, anthropometric, clinical variables, and serum lipid profiles were analyzed. DNA was extracted from blood samples and genotyping of polymorphisms was executed with the TaqMan SNP genotyping assay. Allele and genotypic frequencies were calculated. For genetic association analysis, logistic regression models were fitted according to models of inheritance. RESULTS: The SNP rs662799 (C) was significantly associated with hypertriglyceridemia in the overdominant model (OR=3.89, p=0.001) and AD in the dominant model (OR=4.01, p=0.001). The SNP rs5070 (T) has a protective effect against hypertriglyceridemia in the additive risk model (OR=0.68, p=0.03). CONCLUSION: Polymorphism rs662799 was significantly associated with cases of hypertriglyceridemia and AD in minors in southeastern Mexico. On the other hand, rs5070 polymorphism was not associated with cases of hypertriglyceridemia or AD.


Subject(s)
Atherosclerosis , Dyslipidemias , Hypertriglyceridemia , Humans , Child , Mexico , Apolipoprotein A-V/genetics , Genotype , Hypertriglyceridemia/genetics , Polymorphism, Single Nucleotide , Atherosclerosis/genetics , Dyslipidemias/genetics , Genetic Predisposition to Disease , Gene Frequency , Triglycerides
3.
Pharmacogenet Genomics ; 32(3): 101-110, 2022 04 01.
Article in English | MEDLINE | ID: mdl-34693928

ABSTRACT

OBJECTIVE: To investigate the impact of single nucleotide polymorphisms (SNPs) from APOA5, APOC3, CETP, ATP binding cassette transporter A1 and SIK3 genes in the development of hypertriglyceridemia in HIV patients under antiretroviral therapy. MATERIAL AND METHODS: A case-control study was developed. Leukocytic genomic DNA was extracted and genotyping for SNPs rs662799, rs964184, rs5128, rs2854116, rs2854117, rs3764261, rs4149310, rs4149267 and rs139961185 was performed by real time-PCR using TaqMan allelic discrimination assays, in Mexican mestizo patients with HIV infection, with hypertriglyceridemia (>1.7 mmol/L) under antiretroviral therapy. Genetic variants were also investigated in a control group of normolipidemic HIV patients (≤ 1.7 mmol/L). Haplotypes and gene interactions were analyzed. RESULTS: A total of 602 HIV patients were genotyped (316 cases and 286 controls). Age and antiretroviral regimen based on protease inhibitors were associated with hypertriglyceridemia (P = 0.0001 and P = 0.0002. respectively). SNP rs964184 GG genotype in APOA5 gene exhibited the highest association with hypertriglyceridemia risk (OR, 3.2, 95% CI, 1.7-5.8, P = 0.0001); followed by SNP rs139961185 in SIK3 gene (OR = 2.3; (95% CI, 1.1-4.8; P = 0.03 for AA vs. AG genotype; and APOC3 rs5128 GG genotype, (OR, 2.2; 95% CI, 1.1-4.9; P = 0.04) under codominant models. These associations were maintained in the adjusted analysis by age and protease inhibitors based antiretroviral regimens. CONCLUSIONS: This study reveals an association between rs964184 in APOA5; rs5128 in APOC3 and rs139961185 in SIK3 and high triglyceride concentrations in Mexican HIV-patients receiving protease inhibitors. These genetic factors may influence the adverse effects related to antiretroviral therapy.


Subject(s)
Anti-HIV Agents , HIV Infections , Hypertriglyceridemia , ATP Binding Cassette Transporter 1/genetics , Anti-HIV Agents/adverse effects , Anti-HIV Agents/therapeutic use , Apolipoprotein A-V/genetics , Apolipoprotein C-III/genetics , Case-Control Studies , Cholesterol Ester Transfer Proteins/genetics , Genotype , HIV Infections/complications , HIV Infections/drug therapy , HIV Infections/genetics , Humans , Hypertriglyceridemia/chemically induced , Hypertriglyceridemia/genetics , Mexico , Polymorphism, Single Nucleotide , Protein Kinases , Triglycerides
4.
Rev. Univ. Ind. Santander, Salud ; 53(1): e320, Marzo 12, 2021. tab, graf
Article in Spanish | LILACS | ID: biblio-1365450

ABSTRACT

Resumen Introducción: Es importante identificar los polimorfismos de interés clínico en patologías complejas como el Síndrome Metabólico. Por esto, las metodologías para su evaluación deben estar diseñadas y validadas correctamente, esto permite optimizar recursos y tiempo en la genotipificación y detección correcta de los alelos presentes en los individuos. Objetivo: Diseñar y validar una PCR múltiple, seguida de detección por minisecuenciación, para la genotipificación de ocho polimorfismos de nucleótido simple ubicados en el gen del Receptor Beta 3-Adrenérgico (rs4994 y rs4998), gen de la Apolipoproteina A5 (rs3135506 y rs2075291), gen de la Adiponectina (rs1501299 y rs2241766) y gen del Receptor Activador de la Proliferación de los Peroxisomas tipo gamma (rs1801282 y rs1800571), asociados con el síndrome metabólico. Materiales y métodos: Se diseñaron 24 cebadores para la amplificación y detección de ocho polimorfismos de nucleótido sencillo ubicados en cuatro genes candidatos a estar asociados con el síndrome metabólico, usando el software Primer3®. Dieciséis fueron diseñados para amplificar los polimorfismos y ocho para detectarlos por minisecuenciación. Las estructuras secundarias entre los cebadores se verificaron con el software Autodimer. Los polimorfismos se amplificaron simultáneamente y los fragmentos amplificados se acoplaron a las sondas diseñadas para detectar por minisecuenciación el alelo presente, por medio de bases marcadas con fluorocromos. Finalmente, los alelos fueron detectados por electroforesis capilar en un analizador genético ABI 310 y se interpretaron con el software GeneMapper®. La validación del multiplex se realizó genotipando 20 muestras de individuos, cada uno de ellos autorizó este procedimiento por medio del consentimiento informado. Resultados: Se obtuvieron los perfiles genéticos de los 20 controles genotipados, a partir de la amplificación múltiple, seguida de minisecuenciación, diseñada y validada para detectar los ocho polimorfismos. Conclusión: Se diseñó y validó un ensayo para la detección simultánea de los polimorfismos, ubicados en cuatro genes asociados con el Síndrome metabólico. Los cuales pueden ser empleados como referencia para futuros estudios poblacionales.


Abstract Introduction: It is important to identify the polymorphisms of clinical interest in complex pathologies such as Metabolic Syndrome. Therefore, the methodologies for its evaluation must be designed and validated correctly, this permits optimization of resources and time in genotyping and correct detection of the alleles present in individuals. Objective: To design and validate a multiplex PCR, followed by detection by minisequencing, for the genotyping of eight single nucleotide polymorphisms located in the Beta 3-Adrenergic Receptor gene (rs4994 and rs4998), Apolipoprotein A5 gene (rs3135506 and rs2075291), Adiponectin gene (rs1501299 and rs2241766) and gamma-type Peroxisome Proliferation Activating Receptor gene (rs1801282 and rs1800571), associated with metabolic syndrome. Materials and methods: Twenty-four primers were designed for the amplification and detection of eight single nucleotide polymorphisms located in four candidate genes to be associated with the metabolic syndrome, using the Primer3® software. Sixteen were designed to amplify the polymorphisms and eight to detect them by minisequencing. The secondary structures between the primers were verified with Autodimer software. The polymorphisms were simultaneously amplified, and the amplified fragments were coupled to probes designed to minisequence the present allele using fluorochrome-labeled bases. Finally, the alleles were detected by capillary electrophoresis using an ABI 310 genetic analyzer and analyzed with the GeneMapper® software. The validation of the multiplex was performed by genotyping 20 individual samples, each of them authorized this procedure through informed consent. Results: The genetic profiles of the 20 genotyped controls were obtained, from multiple amplification, followed by minisequencing, designed and validated to detect the eight polymorphisms. Conclusion: An essay was designed and validated for the simultaneous detection of polymorphisms, located in four genes associated with metabolic syndrome, and can used as a reference for future population studies.


Subject(s)
Humans , Electrophoresis, Capillary , Polymorphism, Single Nucleotide , Metabolic Syndrome , Receptors, Adrenergic, beta-3 , PPAR gamma , Adiponectin , Apolipoprotein A-V
5.
Lipids Health Dis ; 20(1): 14, 2021 Feb 15.
Article in English | MEDLINE | ID: mdl-33588820

ABSTRACT

BACKGROUND: Familial hypertriglyceridemia (FHTG) is a partially characterized primary dyslipidemia which is frequently confused with other forms hypertriglyceridemia. The aim of this work is to search for specific features that can help physicians recognize this disease. METHODS: This study included 84 FHTG cases, 728 subjects with common mild-to-moderate hypertriglyceridemia (CHTG) and 609 normotriglyceridemic controls. All subjects underwent genetic, clinical and biochemical assessments. A set of 53 single nucleotide polymorphisms (SNPs) previously associated with triglycerides levels, as well as 37 rare variants within the five main genes associated with hypertriglyceridemia (i.e. LPL, APOC2, APOA5, LMF1 and GPIHBP1) were analyzed. A panel of endocrine regulatory proteins associated with triglycerides homeostasis were compared between the FHTG and CHTG groups. RESULTS: Apolipoprotein B, fibroblast growth factor 21(FGF-21), angiopoietin-like proteins 3 (ANGPTL3) and apolipoprotein A-II concentrations, were independent components of a model to detect FHTG compared with CHTG (AUC 0.948, 95%CI 0.901-0.970, 98.5% sensitivity, 92.2% specificity, P < 0.001). The polygenic set of SNPs, accounted for 1.78% of the variance in triglyceride levels in FHTG and 6.73% in CHTG. CONCLUSIONS: The clinical and genetic differences observed between FHTG and CHTG supports the notion that FHTG is a unique entity, distinguishable from other causes of hypertriglyceridemia by the higher concentrations of insulin, FGF-21, ANGPTL3, apo A-II and lower levels of apo B. We propose the inclusion of these parameters as useful markers for differentiating FHTG from other causes of hypertriglyceridemia.


Subject(s)
Angiopoietin-like Proteins/genetics , Apolipoprotein A-II/genetics , Fibroblast Growth Factors/genetics , Hyperlipoproteinemia Type IV/diagnosis , Hypertriglyceridemia/diagnosis , Adult , Angiopoietin-Like Protein 3 , Apolipoprotein A-V/genetics , Apolipoprotein C-II/genetics , Apolipoproteins B/genetics , Diagnosis, Differential , Female , Humans , Hyperlipoproteinemia Type IV/genetics , Hyperlipoproteinemia Type IV/metabolism , Hyperlipoproteinemia Type IV/pathology , Hypertriglyceridemia/genetics , Hypertriglyceridemia/metabolism , Hypertriglyceridemia/pathology , Insulin/genetics , Lipoprotein Lipase/genetics , Male , Membrane Proteins/genetics , Middle Aged , Polymorphism, Single Nucleotide/genetics , Receptors, Lipoprotein/genetics , Triglycerides/genetics
6.
Blood Cells Mol Dis ; 80: 102376, 2020 02.
Article in English | MEDLINE | ID: mdl-31670185

ABSTRACT

This cross-sectional study investigated associations between SNPs in metabolizing lipid genes, alpha-thalassemia and laboratory parameters in two forms of sickle cell disease (SCD), sickle cell anemia (SCA) and hemoglobin SC disease (HbSC) in a pediatric population. Among the groups SCA and HbSC was found a higher proportion of increased triglycerides (TG) in SCA. High levels of TG were significantly associated with lower hemoglobin (p = 0.006) and HDL-C (p = 0.037), higher white blood cell count (p = 0.027), LDH (p = 0.004) and bilirubins (p < 0.05) in SCD. Patients with HDL-C ≤40 mg/dL had higher markers hemolytic levels. Therapy of HU significantly influenced several hematological and biochemical parameters but not lipid fractions. Genotypes of the APOA5 rs662799 were not associated with lipid levels. The G-risk allele rs964184/ZPRI ZNF259/ZPR1 gene (GC + GG genotypes) was associated with increased levels of TG in children ≥10 years old (p = 0.045) and the atherogenic ratio TG/HDL-C (p = 0.032) in SCD. The use of HU improves levels of hemolysis and inflammation markers in SCD with high TG and, while not interfering with lipid levels, seems to overlap the effect of the G-risk allele in on them. This study reported for the first time that rs964184 SNP could be a genetic modifier of TG in SCD.


Subject(s)
Anemia, Sickle Cell/blood , Anemia, Sickle Cell/genetics , Apolipoprotein A-V/genetics , Genetic Association Studies , Lipids/blood , Membrane Transport Proteins/genetics , Polymorphism, Genetic , Adolescent , Adult , Age Factors , Alleles , Anemia, Sickle Cell/epidemiology , Biomarkers , Blood Cell Count , Blood Chemical Analysis , Brazil/epidemiology , Child , Cross-Sectional Studies , Female , Genotype , Hemoglobin SC Disease/blood , Hemoglobin SC Disease/epidemiology , Hemoglobin SC Disease/genetics , Humans , Male , Middle Aged , Phenotype , Polymorphism, Single Nucleotide , Population Surveillance , Young Adult
7.
Mol Genet Genomic Med ; 7(9): e931, 2019 09.
Article in English | MEDLINE | ID: mdl-31397093

ABSTRACT

BACKGROUND: Male EBP disorder with neurologic defects (MEND) syndrome is an X-linked disease caused by hypomorphic mutations in the EBP (emopamil-binding protein) gene. Modifier genes may explain the clinical variability among individuals who share a primary mutation. METHODS: We studied four males (Patient 1 to Patient 4) exhibiting a descending degree of phenotypic severity from a family with MEND syndrome. To identify candidate modifier genes that explain the phenotypic variability, variants of homeostasis cholesterol genes identified by whole-exome sequencing (WES) were ranked according to the predicted magnitude of their effect through an in-house scoring system. RESULTS: Twenty-seven from 105 missense variants found in 45 genes of the four exomes were considered significant (-5 to -9 scores). We found a direct genotype-phenotype association based on the differential accumulation of potentially functional gene variants among males. Patient 1 exhibited 17 variants, both Patients 2 and 3 exhibited nine variants, and Patient 4 exhibited only five variants. CONCLUSION: We conclude that APOA5 (rs3135506), ABCA1 (rs9282541), and APOB (rs679899 and rs12714225) are the most relevant candidate modifier genes in this family. Relative accumulation of the deficiencies associated with variants of these genes along with other lesser deficiencies in other genes appears to explain the variable expressivity in MEND syndrome.


Subject(s)
ATP Binding Cassette Transporter 1 , Apolipoprotein A-V , Apolipoprotein B-100 , Cholesterol , Exome , Polymorphism, Genetic , Waardenburg Syndrome , ATP Binding Cassette Transporter 1/genetics , ATP Binding Cassette Transporter 1/metabolism , Apolipoprotein A-V/genetics , Apolipoprotein A-V/metabolism , Apolipoprotein B-100/genetics , Apolipoprotein B-100/metabolism , Cholesterol/genetics , Cholesterol/metabolism , Female , Genetic Association Studies , Homeostasis/genetics , Humans , Male , Phenotype , Severity of Illness Index , Waardenburg Syndrome/genetics , Waardenburg Syndrome/metabolism , Waardenburg Syndrome/pathology
8.
Arq. bras. cardiol ; Arq. bras. cardiol;111(3 supl.1): 187-187, set., 2018. tab.
Article in Portuguese | Sec. Est. Saúde SP, SESSP-IDPCPROD, Sec. Est. Saúde SP | ID: biblio-1046052

ABSTRACT

INTRODUÇÃO: A apolipoproteína A-V regula a produção e secreção de lipoproteína de densidade muito baixa (VLDL) pelo fígado, estimula a hidrólise de triglicerídeos (TG) mediada pela lipoproteína lipase (LPL) e atua na captação hepática de lipoproteínas ricas em TG e seus remanescentes. Alterações no gene APOA5 podem modificar a função e causar hipertrigliceridemia. Estudos in silico indicam que a variante rs3135506 c.56G>C pode diminuir a expressão de APOA5 e aumentar a secreção de VLDL. OBJETIVO: Investigar a influência da variante c.56G>C no perfil lipídico de indivíduos com hipercolesterolemia familial (HF). Métodos: Foram selecionados 35 indivíduos com diagnóstico clínico de HF segundo o critério Dutch-MEDPED e idade superior a 18 anos. Amostras de sangue foram obtidas para análise do perfil lipídico e sequenciamento. Dos 35 pacientes sequenciados, 22 obtiveram diagnóstico molecular para HF. Os éxons do APOA5 foram analisados por sequenciamento de alto rendimento utilizando a plataforma MiSeq (Illumina). As análises primária, secundária e terciária dos dados foram realizadas com os programas Real Time Analysis, MiSeq Reporter, BaseSpace Sequence Hub e VariantStudio. RESULTADOS: A variante rs3135506 foi detectada em 12 pacientes (Genótipo GC:34,3%). Os portadores do genótipo c.56GC tiveram maiores concentrações de TG e VLDL-c e menores de HDL-c que os portadores do genótipo c.56GG (Tabela 1). Os indivíduos HF foram categorizados segundo a presença ou não de hipertrigliceridemia (TG>150 mg/dL). A frequência do genótipo GC foi maior no grupo hipertrigliceridemia (8/15, 53,3%) que no grupo sem hipertrigliceridemia (4/20, 20,0%) (OR=4,57, IC95%:1,03-20,35, p=0,040). CONCLUSÃO: A variante APOA5 rs3135506 está associada a hipertrigliceridemia e HDL-c reduzido em indivíduos HF. (AU)


Subject(s)
Apolipoprotein A-V , Hyperlipoproteinemia Type II
9.
Sci Rep ; 8(1): 5603, 2018 04 04.
Article in English | MEDLINE | ID: mdl-29618726

ABSTRACT

Genome-wide association studies have identified numerous variants associated with lipid levels; yet, the majority are located in non-coding regions with unclear mechanisms. In the Insulin Resistance Atherosclerosis Family Study (IRASFS), heritability estimates suggest a strong genetic basis: low-density lipoprotein (LDL, h2 = 0.50), high-density lipoprotein (HDL, h2 = 0.57), total cholesterol (TC, h2 = 0.53), and triglyceride (TG, h2 = 0.42) levels. Exome sequencing of 1,205 Mexican Americans (90 pedigrees) from the IRASFS identified 548,889 variants and association and linkage analyses with lipid levels were performed. One genome-wide significant signal was detected in APOA5 with TG (rs651821, PTG = 3.67 × 10-10, LODTG = 2.36, MAF = 14.2%). In addition, two correlated SNPs (r2 = 1.0) rs189547099 (PTG = 6.31 × 10-08, LODTG = 3.13, MAF = 0.50%) and chr4:157997598 (PTG = 6.31 × 10-08, LODTG = 3.13, MAF = 0.50%) reached exome-wide significance (P < 9.11 × 10-08). rs189547099 is an intronic SNP in FNIP2 and SNP chr4:157997598 is intronic in GLRB. Linkage analysis revealed 46 SNPs with a LOD > 3 with the strongest signal at rs1141070 (LODLDL = 4.30, PLDL = 0.33, MAF = 21.6%) in DFFB. A total of 53 nominally associated variants (P < 5.00 × 10-05, MAF ≥ 1.0%) were selected for replication in six Mexican-American cohorts (N = 3,280). The strongest signal observed was a synonymous variant (rs1160983, PLDL = 4.44 × 10-17, MAF = 2.7%) in TOMM40. Beyond primary findings, previously reported lipid loci were fine-mapped using exome sequencing in IRASFS. These results support that exome sequencing complements and extends insights into the genetics of lipid levels.


Subject(s)
Atherosclerosis/pathology , Genetic Variation , Lipids/blood , Mexican Americans/genetics , Adult , Apolipoprotein A-V/genetics , Atherosclerosis/genetics , Carrier Proteins/genetics , Female , Genetic Linkage , Genome-Wide Association Study , Humans , Insulin Resistance/genetics , Lipoproteins, HDL/blood , Middle Aged , Polymorphism, Single Nucleotide , Triglycerides/blood , Exome Sequencing
10.
Arch Med Res ; 49(2): 94-100, 2018 02.
Article in English | MEDLINE | ID: mdl-29705673

ABSTRACT

BACKGROUND AND AIMS: Obesity is a complex, chronic, and multifactorial disease that has become a major, and worldwide, public health problem contributing to an increased number of pathologies, including type 2 diabetes, cardiovascular disease, hyperlipidemia, and metabolic syndrome, thus suggesting a commolon origin. A diet high in sugar and fats coupled with a sedentary lifestyle has a major role in the development of obesity. However, the genetic background has also been associated with body fat accumulation. The aim of this study was to assess the effect ofACE-rs4646994, APOA5-rs662799, and MTP-rs1800591 gene polymorphisms on clinical and biochemical parameters and to evaluate the association with body phenotypes in children and adolescent population of Saltillo, Coahuila, Mexico. METHODS: Anthropometric, clinical, biochemical parameters and BMI were obtained from 405 children and adolescents. The BMI was used to determine the body phenotype. The rs4646994 gene polymorphism was determined by PCR, whereas rs662799 and rs1800591 were determined by PCR-RFLP. The obtained results were analyzed to determine their association of these single nucleotide polymorphisms with body phenotype and biochemical parameters. RESULTS: TT genotype for APOA5-rs662799 was associated with increased levels of HDL-C in the analyzed population (p <0.05). The ACErs4646994gene polymorphism is associated with high Insulin levels, HOMAIR index, and triglyceride levels, mainly when presenting a I/I genotype (p <0.05). CONCLUSION: The polymorphic allele of the ACE gene is capable of modulating triglyceride levels, insulin levels and HOMA-IR index in the evaluated population; it must be highlighted that this has not been reported in other studied populations elsewhere.


Subject(s)
Apolipoprotein A-V/genetics , Cholesterol, HDL/genetics , Insulin Resistance/genetics , Insulins/blood , Obesity/genetics , Peptidyl-Dipeptidase A/genetics , Triglycerides/blood , Adolescent , Adult , Alleles , Anthropometry , Child , Cross-Sectional Studies , Female , Genotype , Humans , Male , Mexico , Obesity/pathology , Phenotype , Polymorphism, Single Nucleotide , Risk Factors , Young Adult
11.
J Stroke Cerebrovasc Dis ; 27(5): 1357-1362, 2018 May.
Article in English | MEDLINE | ID: mdl-29398535

ABSTRACT

BACKGROUND: Although there is adequate knowledge as to the role of traditional cardiovascular risk factors on stroke incidence, knowledge of other risk factors, particularly genetic ones, is still incomplete. METHODS: To assess the participation of some polymorphisms, along with other modifiable risk factors, a case-control study was conducted. A total of 253 cases were identified in the emergency room of a general regional hospital, with a clinical trait of stroke confirmed by a skull computerized axial tomography scan. In the surgery ward, 253 controls were identified, gender and age (±5 years) matched. Biochemical parameters were measured, and 4 polymorphisms were genotyped by polymerase chain reaction, rs1801133 (methylenetetrahydrofolate reductase [MTHFR]), rs1498373 (dimethylarginine dimethylaminohydrolase type 1 [DDAH1]), rs662799 (apolipoprotein A5 [APOA5]), and rs1799983 (endothelial nitric oxide). Odds ratios were estimated to assess the strength of association, with 95% confidence intervals, both in a matched case-control analysis and in a conditional regression analysis. RESULTS: Cases had higher mean blood pressure and triglycerides and lower hemoglobin levels. Heterozygous and homozygous subjects to the rs1801133 variant of the MTHFR gene had a 3-fold higher risk of stroke. In the dominant model, those with the polymorphism rs662799 of the promoter region for APOA5 had twice the risk of stroke. Anemia increased the risk of stroke 4-fold. CONCLUSIONS: Polymorphisms of the genes MTHFR (rs1801133) and APOA5 (rs662799), as well as anemia, are independent risk factors for stroke in Mexicans, together with traditional cardiovascular risk factors such as high triglycerides and high blood pressure.


Subject(s)
Anemia/blood , Apolipoprotein A-V/genetics , Brain Ischemia/blood , Brain Ischemia/genetics , Methylenetetrahydrofolate Reductase (NADPH2)/genetics , Polymorphism, Single Nucleotide , Stroke/genetics , Anemia/diagnosis , Anemia/epidemiology , Biomarkers/blood , Blood Pressure , Brain Ischemia/diagnosis , Brain Ischemia/epidemiology , Case-Control Studies , Gene Frequency , Genetic Association Studies , Genetic Predisposition to Disease , Hemoglobins/metabolism , Heterozygote , Homozygote , Humans , Hypertension/epidemiology , Hypertension/physiopathology , Hypertriglyceridemia/blood , Hypertriglyceridemia/epidemiology , Logistic Models , Mexico/epidemiology , Multivariate Analysis , Odds Ratio , Phenotype , Prevalence , Promoter Regions, Genetic , Risk Factors , Stroke/blood , Stroke/diagnosis , Triglycerides/blood
12.
PLoS One ; 12(2): e0172880, 2017.
Article in English | MEDLINE | ID: mdl-28245265

ABSTRACT

We carried out an admixture mapping study of lipid traits in two samples from Mexico City. Native American locus ancestry was significantly associated with triglyceride levels in a broad region of chromosome 11 overlapping the BUD13, ZNF259 and APOA5 genes. In our fine-mapping analysis of this region using dense genome-wide data, rs964184 is the only marker included in the 99% credible set of SNPs, providing strong support for rs964184 as the causal variant within this region. The frequency of the allele associated with increased triglyceride concentrations (rs964184-G) is between 30-40% higher in Native American populations from Mexico than in European populations. The evidence currently available for this variant indicates that it may be exerting its effect through three potential mechanisms: 1) modification of enhancer activity, 2) regulation of the expression of several genes in cis and/or trans, or 3) modification of the methylation patterns of the promoter of the APOA5 gene.


Subject(s)
Apolipoprotein A-V/genetics , Carrier Proteins/genetics , RNA-Binding Proteins/genetics , Triglycerides/blood , Adult , Alleles , Female , Gene Frequency/genetics , Genetic Predisposition to Disease , Genome-Wide Association Study , Haplotypes/genetics , Humans , Linkage Disequilibrium/genetics , Male , Membrane Transport Proteins , Mexican Americans , Middle Aged , Polymorphism, Single Nucleotide/genetics , White People
13.
Pediatr Obes ; 12(4): 330-336, 2017 08.
Article in English | MEDLINE | ID: mdl-27171122

ABSTRACT

BACKGROUND: Dyslipidemia is an important risk factor for the development of several diseases. The genetic component of hypertriglyceridemia has been studied in adults, but little is known in children. OBJECTIVE: The objective is to evaluate the association of two variants in APOA5 (rs662799) and APOA1 (rs5072) with triglyceride (TG) levels in Mexican children. METHODS: Anthropometric parameters were measured in 1559 Mexican children 5-14 years of age. DNA was isolated from blood samples. Lipid profiles and glucose concentrations were determined from serum and genotyping of rs662799, and rs5072 was performed using TaqMan® technology. Additive and dominant models adjusted for age, gender and body mass index were used to evaluate the association of these single nucleotide polymorphisms with TG levels. RESULTS: Children with high TG levels were found to have a higher body mass index and waist circumference as well as a worse lipids profile and glucose levels (p < 0.001). Additive and dominant models demonstrated a significant association between the rs662799 and rs5072 with TG. The dominant model showed the strongest significant association (OR = 1.81; 95% CI 1.46-2.24; p = 5.40 × 10-08 for rs662799 and OR = 1.54; 95% CI 1.05-2.25; p = 2.60 × 10-02 for rs5072). CONCLUSION: The minor alleles of rs662799 (APOA5) and rs5072 (APOA1) modulate TG levels in Mexican children.


Subject(s)
Apolipoprotein A-I/genetics , Apolipoprotein A-V/genetics , Hypertriglyceridemia/genetics , Triglycerides/blood , Adolescent , Alleles , Anthropometry , Child , Child, Preschool , Female , Genotype , Humans , Hypertriglyceridemia/ethnology , Male , Mexican Americans , Polymorphism, Single Nucleotide , Risk Factors
14.
Genet Mol Res ; 15(1)2016 Mar 31.
Article in English | MEDLINE | ID: mdl-27051036

ABSTRACT

Single nucleotide polymorphisms in the APOA5 gene have been studied for their association with metabolic syndrome. Thus, elucidating the effect of the mechanism involved in APOA5 gene polymorphisms on lipid metabolism is of great importance. In this study we aimed to determine the allelic and genotypic frequencies of -1131T>C, Ser19Trp, and intergenic APOA4/A5 and to evaluate the association between these variants with plasma lipid levels in children and adolescents from Brazil. This study included 524 healthy children and adolescents from Mother and Child Hospital in Recife, Pernambuco, Brazil. Data were obtained on medical history, drug intake, lifestyle variables, and demography. DNA from collected samples was extracted and genotyped for the three polymorphisms. In this studied population, triglycerides and very low-density protein levels were significantly high in subjects carrying the 19WW genotype (P < 0.001), demonstrating the presence of this genetic risk factor in children and adolescents.


Subject(s)
Apolipoprotein A-V/genetics , Lipid Metabolism/genetics , Polymorphism, Single Nucleotide , Adolescent , Brazil , Child , Female , Humans , Lipoproteins, LDL/blood , Male , Triglycerides/blood
15.
Genet Mol Res ; 14(4): 12330-9, 2015 Oct 09.
Article in English | MEDLINE | ID: mdl-26505382

ABSTRACT

Although many studies have investigated the association of the APOA5 -1131T/C polymorphism with coronary artery disease (CAD), definite conclusions have not been drawn. To understand the effects of the APOA5 -1131T/C polymorphism on the risk of developing CAD, we performed an updated meta-analysis in the Chinese population. Relevant studies published till April 2015 were identified from databases such as PubMed, Springer Link, Ovid, Chinese Wanfang Data Knowledge Service Platform, Chinese National Knowledge Infrastructure, and Chinese Biology Medicine. A total of 19 studies including 3983 patients and 4358 controls were involved in this meta-analysis. The crude OR with 95%CI was calculated to assess the strength of the association. With the pooled data from the studies included in this meta-analysis, we found a significant association between the APOA5 -1131T/C polymorphism and CAD risk in the Chinese population (C vs T: OR = 1.34, 95%CI = 1.16-1.54; CC vs TT: OR = 1.73, 95%CI = 1.30-2.30; CC vs TT and TC: OR = 1.51, 95%CI = 1.17-1.95; CC vs TC: OR = 1.30, 95%CI = 1.03-1.65). Stratified analyses according to the geographical location and source of controls revealed significantly increased risk in South China and in population-based studies. In conclusion, our meta-analysis provides substantial evidence that the APOA5 -1131T/C polymorphism might contribute to CAD development in the Chinese population.


Subject(s)
Apolipoproteins A/genetics , Coronary Artery Disease/genetics , Genetic Predisposition to Disease/genetics , Polymorphism, Single Nucleotide/genetics , Apolipoprotein A-V , Asian People/genetics , Humans
16.
Lipids Health Dis ; 14: 106, 2015 Sep 13.
Article in English | MEDLINE | ID: mdl-26365669

ABSTRACT

BACKGROUND: Diet is an important environmental factor that interacts with genes to modulate the likelihood of developing disorders in lipid metabolism and the relationship between diet and genes in the presence of other chronic diseases such as obesity. The objective of this study was to analyze the interaction of a high fat diet with the APOA2 (rs3813627 and rs5082), APOA5 (rs662799 and rs3135506) and LEPR (rs8179183 and rs1137101) polymorphisms and its relationship with obesity and dyslipidemia in young subjects. METHODS: The study included 200 young subjects aged 18 to 25 years (100 normal-weight and 100 obese subjects). Dietary fat intake was measured using the frequency food consumption questionnaire. Genotyping of polymorphisms was performed by PCR-RFLP. RESULTS: Individuals carrying the APOA5 56 G/G genotype with a high saturated fatty acid consumption (OR = 2.7, p = 0.006) and/or total fat (OR = 2.4, p = 0.018), associated with an increased risk of obesity. We also found that A/G + G/G genotypes of the 668 A/G polymorphism in the LEPR gene with an intake ≥ 12 g/d of saturated fatty acids, have 2.9 times higher risk of obesity (p = 0.002), 3.8 times higher risk of hypercholesterolemia (p = 0.002) and 2.4 times higher risk of hypertriglyceridemia (p = 0.02), than those with an intake <12 g/d of saturated fatty acids. Similarly, LEPR 668 A/G + G/G carriers with a high fat total intake had 3.0 times higher risk of obesity (p = 0.002) and 4.1 times higher risk of hypercholesterolemia (p = 0.001). CONCLUSION: Our results suggest that dietary fat intake modifies the effect of APOA5 and LEPR polymorphisms on serum triglycerides, cholesterol levels and obesity in young subjects.


Subject(s)
Apolipoprotein A-II/genetics , Apolipoproteins A/genetics , Diet, High-Fat/adverse effects , Dietary Fats/adverse effects , Dyslipidemias/genetics , Obesity/genetics , Polymorphism, Single Nucleotide , Adolescent , Adult , Apolipoprotein A-II/blood , Apolipoprotein A-V , Apolipoproteins A/blood , Blood Glucose/metabolism , Case-Control Studies , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Dyslipidemias/blood , Dyslipidemias/etiology , Dyslipidemias/pathology , Fasting , Fatty Acids/blood , Female , Gene Expression , Genotype , Humans , Male , Obesity/blood , Obesity/etiology , Obesity/pathology , Receptors, Leptin , Risk , Surveys and Questionnaires , Triglycerides/blood
17.
Exp Biol Med (Maywood) ; 240(1): 79-86, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25073959

ABSTRACT

Apolipoprotein gene polymorphism has an important role in lipid metabolism and in the development of cerebro- and cardio-vascular disease (CCVD), including dementia. Dyslipidemia and hemostatic abnormalities are key risk factors associated with athero-sclerotic events preceding CCVD. The aim of this study was to evaluate the possible relationships of various apolipoprotein-species with hemostatic parameters and cognitive function. Lipid profile, gene polymorphism, coagulation markers, and mini-mental state examination (MMSE) scores were assessed in 109 dys-lipidemic subjects and in 107 healthy control volunteers. Thrombin-activatable fibrinolysis inhibitor (TAFI) plasma levels were significantly higher in apolipoprotein-E2 (apoE2) patients when compared to other apoE forms. The apoA5 -1131T>C polymorphism was associated with elevated D-dimer concentration in dyslipidemic TT homozygous individuals. MMSE did not correlate with lipid or coagulation profile. These data suggest that apoE and apoA5 variants have an effect on hemostatic parameters, but they neither influence nor predict cognitive performance in non-demented individuals.


Subject(s)
Apolipoproteins A/genetics , Apolipoproteins E/genetics , Dyslipidemias/complications , Genetic Predisposition to Disease , Polymorphism, Genetic , Thrombosis/epidemiology , Thrombosis/genetics , Adult , Apolipoprotein A-V , Dementia/epidemiology , Dementia/genetics , Female , Humans , Male , Middle Aged
18.
Genet Mol Res ; 14(4): 18218-28, 2015 Dec 28.
Article in English | MEDLINE | ID: mdl-26782469

ABSTRACT

The aim of this study was to investigate correlations between apolipoprotein A-V (APOA5) -1131T>C and apolipoprotein C-III (APOC3) -455T>C polymorphisms and coronary heart disease (CHD). PubMed, Ovid, Cochrane Library, Embase, China National Knowledge Infrastructure, and Wanfang databases were searched using combinations of keywords relating to these polymorphisms and CHD. Studies retrieved from database searches were screened using our stringent inclusion and exclusion criteria, and Comprehensive Meta-Analysis Version 2.0 software was used for statistical analyses. In total, 115 studies were initially retrieved and after further selection, 11 were included in the meta-analysis. These 11 articles comprised 4840 patients with CHD in the case group and 4913 healthy participants in the control group. Meta-analysis revealed that APOA5 -1131T>C and APOC3 -455T>C polymorphisms increased CHD risk. In addition, subgroup analysis by ethnicity showed that while the -1131T>C polymorphism elevated the risk of CHD in the Caucasian population under both allelic and dominant models, this increased risk was observed only under a dominant model in the Asian population. The results of our meta-analysis point to a strong link between both APOA5 -1131T>C and APOC3 -455T>C polymorphisms and an increased risk of CHD. Thus, these polymorphisms constitute important predictive indicators of CHD susceptibility.


Subject(s)
Apolipoprotein C-III/genetics , Apolipoproteins A/genetics , Coronary Disease/genetics , Genetic Association Studies , Alleles , Apolipoprotein A-V , China , Genetic Predisposition to Disease , Humans , Polymorphism, Single Nucleotide , Risk Factors , White People
19.
Nat Commun ; 5: 3983, 2014 Jun 02.
Article in English | MEDLINE | ID: mdl-24886709

ABSTRACT

Dyslipidemia and obesity are especially prevalent in populations with Amerindian backgrounds, such as Mexican-Americans, which predispose these populations to cardiovascular disease. Here we design an approach, known as the cross-population allele screen (CPAS), which we conduct prior to a genome-wide association study (GWAS) in 19,273 Europeans and Mexicans, in order to identify Amerindian risk genes in Mexicans. Utilizing CPAS to restrict the GWAS input variants to only those differing in frequency between the two populations, we identify novel Amerindian lipid genes, receptor-related orphan receptor alpha (RORA) and salt-inducible kinase 3 (SIK3), and three loci previously unassociated with dyslipidemia or obesity. We also detect lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) harbouring specific Amerindian signatures of risk variants and haplotypes. Notably, we observe that SIK3 and one novel lipid locus underwent positive selection in Mexicans. Furthermore, after a high-fat meal, the SIK3 risk variant carriers display high triglyceride levels. These findings suggest that Amerindian-specific genetic architecture leads to a higher incidence of dyslipidemia and obesity in modern Mexicans.


Subject(s)
Hypercholesterolemia/genetics , Hypertriglyceridemia/genetics , Indians, North American/genetics , Obesity/genetics , Adult , Apolipoprotein A-V , Apolipoproteins A/genetics , Case-Control Studies , Chromosomes, Human, Pair 11/genetics , Chromosomes, Human, Pair 8/genetics , Dyslipidemias/genetics , Female , Genetic Predisposition to Disease , Genome-Wide Association Study , Genotype , Haplotypes , Humans , Lipoprotein Lipase/genetics , Logistic Models , Male , Mexico/ethnology , Middle Aged , Nuclear Receptor Subfamily 1, Group F, Member 1/genetics , Polymorphism, Single Nucleotide , Protein Kinases/genetics , White People/genetics , Young Adult
20.
Metabolism ; 63(7): 887-94, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24768220

ABSTRACT

Here, we discuss potential explanations for the higher prevalence of hypertriglyceridemia in populations with an Amerindian background. Although environmental factors are the triggers, the search for the ethnic related factors that explain the increased susceptibility of the Amerindians is a promising area for research. The study of the genetics of hypertriglyceridemia in Hispanic populations faces several challenges. Ethnicity could be a major confounding variable to prove genetic associations. Despite that, the study of hypertriglyceridemia in Hispanics has resulted in significant contributions. Two GWAS reports have exclusively included Mexican mestizos. Fifty percent of the associations reported in Caucasians could be generalized to the Mexicans, but in many cases the Mexican lead SNP was different than that reported in Europeans. Both reports included new associations with apo B or triglycerides concentrations. The frequency of susceptibility alleles in Mexicans is higher than that found in Europeans for several of the genes with the greatest effect on triglycerides levels. An example is the SNP rs964184 in APOA5. The same trend was observed for ANGPTL3 and TIMD4 variants. In summary, we postulate that the study of the genetic determinants of hypertriglyceridemia in Amerindian populations which have major changes in their lifestyle, may prove to be a great resource to identify new genes and pathways associated with hypertriglyceridemia.


Subject(s)
Angiopoietins/genetics , Apolipoproteins A/genetics , Apolipoproteins B/genetics , Gene-Environment Interaction , Hypertriglyceridemia/etiology , Membrane Proteins/genetics , Polymorphism, Genetic , Angiopoietin-Like Protein 3 , Angiopoietin-like Proteins , Angiopoietins/metabolism , Apolipoprotein A-V , Apolipoproteins A/metabolism , Apolipoproteins B/metabolism , Disease Susceptibility , Genetic Predisposition to Disease , Hispanic or Latino , Humans , Hyperlipidemia, Familial Combined/etiology , Hyperlipidemia, Familial Combined/genetics , Hyperlipidemia, Familial Combined/metabolism , Hyperlipoproteinemia Type III/etiology , Hyperlipoproteinemia Type III/genetics , Hyperlipoproteinemia Type III/metabolism , Hyperlipoproteinemia Type IV/etiology , Hyperlipoproteinemia Type IV/genetics , Hyperlipoproteinemia Type IV/metabolism , Hypertriglyceridemia/genetics , Hypertriglyceridemia/metabolism , Indians, Central American , Indians, North American , Membrane Proteins/metabolism , Mexico/ethnology , Multifactorial Inheritance , United States
SELECTION OF CITATIONS
SEARCH DETAIL